-
GSK reports £8.1 billion in Q2 sales
europeanpharmaceuticalreview
August 04, 2021
GSK announces “excellent” Q2 financial performance with growth across all segments – Pharmaceuticals, Vaccines, Consumer Healthcare.
-
Pharmacy Exec Behind Meningitis Outbreak Gets Longer Prison Sentence
drugs
July 09, 2021
A longer prison sentence has been handed to the founder of a now-closed Massachusetts pharmaceutical facility responsible for the 2012 meningitis outbreak that killed 100 people and sickened hundreds of others.
-
First patients dosed in GSK’s Phase III meningitis vaccine trial
europeanpharmaceuticalreview
August 28, 2020
The trial will assess the safety, tolerability and immunogenicity of the five-in-one MenABCWY vaccine in participants aged 10 to 25.
-
First trial participant gets GSK's 5-in-1 meningitis jab
pharmatimes
August 21, 2020
Patient dosing has begun in a Phase III clinical programme investigating GlaxoSmithKline's 5-in-1 meningitis (MenABCWY) vaccine candidate compared to licensed meningococcal vaccines, Bexsero and Menveo.
-
Hilleman Labs is developing a liquid form of meningococcal vaccine in a single container closure
expresspharma
August 10, 2020
Hilleman Labs (HL) has been working on the development of vaccine technologies against some of the key causes of bacterial meningitis.
-
Health officials urge young people to get meningitis jab
pharmatimes
August 17, 2017
Public Health England and the Royal College of Nursing are urging new university students to get vaccinated against meningitis so that they can build immunity to the disease before fresher’s week
-
WHO partners with MRF to work on meningitis
biospectrumasia
August 03, 2017
WHO representatives will be putting meningitis high on the global agenda and coordinating progress in five areas.
-
Scientists Discover Nasal Spray To Prevent Meningitis
pharmanewsonline
March 30, 2017
It is effective against both meningitis B and septicaemia.